Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1/Phase 2"
topic_facet:"Lymphoma"
topic_facet:"Lymphoma, B-Cell"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&filter%5B%5D=topic_facet%3A%22Lymphoma%2C+B-Cell%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&filter%5B%5D=topic_facet%3A%22Lymphoma%2C+B-Cell%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&filter%5B%5D=topic_facet%3A%22Lymphoma%2C+B-Cell%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (70)
1
Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCL : A Phase I/II Clinical Trial to Evaluate the Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab Combination (BeGeRN) in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) : A Phase IB/II Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus CHOP in Patients With Follicular Lymphoma or Rituximab Plus CHOP in Patients With Diffuse Large B-Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma : An Open Label, Single Arm, Phase I/II in the Combination of Azacytidine, Bendamustine and Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients : An Open-label, Multi-center, Single-arm Phase 1/2 Study to Assess Tolerability, Safety and Efficacy of CRC01 in Adult Patients With Relapsed or Refractory Large B-cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
A Phase I/II Study of Diffuse Large B-cell Lymphoma : A Phase I/II Study of Relapse/Refractory Diffuse Large B-cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML : Phase I/II Study of Anti-CD19 Chimeric Antigen Receptor-Expressing T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia and Diffuse Large B Cell Lymphoma (DLBCL) or Primary Mediastinal B Cell Lymphoma (PML)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL : Camrelizumab in Combination With Apatinib in in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma: a Phase Ib/II, Multicentre, Open-label, Single-arm Trial
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL : Tislelizumab in Combination With Lenalidomide in in Patients With Relapsed or Refractory Elderly Patients With Non-GCB Diffuse Large B Cell Lymphoma: a Prospective Phase Ib/II, Multicentre, Open-label, Single-arm Trial
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
QUILT-3.002: ALT-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab : A Phase 1/2 Study of ALT-803 in Patients With Relapse/Refractory Indolent B Cell Non-Hodgkin Lymphoma in Conjunction With Rituximab
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
Induced-T Cell Like NK Cells for B Cell Malignancies : Induced-T Cell Like NK Cellular Immunotherapy for Refractory B Cell Malignancies
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
4
5
6
7
Nächster »
[7]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1/Phase 2
Filter aufheben
Thema: Lymphoma
Filter aufheben
Thema: Lymphoma, B-Cell
Medienart
70
Aufsätze
70
E-Artikel
70
E-Ressourcen
Zeitschriftentitel
70
ClinicalTrials.gov
Thema
70
610
Lymphoma
Lymphoma, B-Cell
Phase: Phase 1/Phase 2
70
Study Type: Interventional
37
Lymphoma, Large B-Cell, Diffuse
28
Recruitment Status: Completed
25
Lymphoma, Non-Hodgkin
17
Lymphoma, Mantle-Cell
13
Lymphoma, Follicular
12
Recruitment Status: Terminated
11
Leukemia, Lymphocytic, Chronic, B-Cell
11
Recruitment Status: Unknown status
10
Leukemia
9
Leukemia, Lymphoid
9
Lymphoma, B-Cell, Marginal Zone
9
Recruitment Status: Recruiting
8
Burkitt Lymphoma
8
Waldenstrom Macroglobulinemia
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
30
2020-
40
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
70
Englisch
Haven't found what you're looking for?
Wird geladen...